N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide

C111H99N27O7S2 — CID 159248417

IUPACN-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide
SMILESCC(C)S(=O)(=O)Nc1ccc(-c2nccn3cc(-c4cnn(C)c4)cc23)cc1.Cn1cc(-c2cc3c(-c4ccc(NC(=O)Cc5ccccc5)cc4)nccn3c2)cn1.Cn1cc(-c2cc3c(-c4ccc(NC(=O)Cc5ccccn5)cc4)nccn3c2)cn1.Cn1cc(-c2cc3c(-c4ccc(NC(=O)Cc5cccnc5)cc4)nccn3c2)cn1.Cn1cc(-c2cc3c(-c4ccc(NS(C)(=O)=O)cc4)nccn3c2)cn1
InChIInChI=1S/C25H21N5O.2C24H20N6O.C20H21N5O2S.C18H17N5O2S/c1-29-16-21(15-27-29)20-14-23-25(26-11-12-30(23)17-20)19-7-9-22(10-8-19)28-24(31)13-18-5-3-2-4-6-18;1-29-15-20(14-27-29)19-12-22-24(26-9-10-30(22)16-19)18-4-6-21(7-5-18)28-23(31)11-17-3-2-8-25-13-17;1-29-15-19(14-27-29)18-12-22-24(26-10-11-30(22)16-18)17-5-7-20(8-6-17)28-23(31)13-21-4-2-3-9-25-21;1-14(2)28(26,27)23-18-6-4-15(5-7-18)20-19-10-16(13-25(19)9-8-21-20)17-11-22-24(3)12-17;1-22-11-15(10-20-22)14-9-17-18(19-7-8-23(17)12-14)13-3-5-16(6-4-13)21-26(2,24)25/h2-12,14-17H,13H2,1H3,(H,28,31);2-10,12-16H,11H2,1H3,(H,28,31);2-12,14-16H,13H2,1H3,(H,28,31);4-14,23H,1-3H3;3-12,21H,1-2H3
InChIKeyKUYXUKLDHZNQQQ-UHFFFAOYSA-N
MW1987.33 g/mol
LogP18.86
Rot. Bonds24

About N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide

N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide (PubChem CID 159248417) has the molecular formula C111H99N27O7S2 and a molecular weight of 1987.33 g/mol. Its IUPAC name is N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide.

Molecular Properties

Compound NameN-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide
PubChem CID159248417
Molecular FormulaC111H99N27O7S2
Molecular Weight1987.33 g/mol
Exact Mass1985.77
IUPAC NameN-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide
SMILESCC(C)S(=O)(=O)Nc1ccc(-c2nccn3cc(-c4cnn(C)c4)cc23)cc1.Cn1cc(-c2cc3c(-c4ccc(NC(=O)Cc5ccccc5)cc4)nccn3c2)cn1.Cn1cc(-c2cc3c(-c4ccc(NC(=O)Cc5ccccn5)cc4)nccn3c2)cn1.Cn1cc(-c2cc3c(-c4ccc(NC(=O)Cc5cccnc5)cc4)nccn3c2)cn1.Cn1cc(-c2cc3c(-c4ccc(NS(C)(=O)=O)cc4)nccn3c2)cn1
InChIInChI=1S/C25H21N5O.2C24H20N6O.C20H21N5O2S.C18H17N5O2S/c1-29-16-21(15-27-29)20-14-23-25(26-11-12-30(23)17-20)19-7-9-22(10-8-19)28-24(31)13-18-5-3-2-4-6-18;1-29-15-20(14-27-29)19-12-22-24(26-9-10-30(22)16-19)18-4-6-21(7-5-18)28-23(31)11-17-3-2-8-25-13-17;1-29-15-19(14-27-29)18-12-22-24(26-10-11-30(22)16-18)17-5-7-20(8-6-17)28-23(31)13-21-4-2-3-9-25-21;1-14(2)28(26,27)23-18-6-4-15(5-7-18)20-19-10-16(13-25(19)9-8-21-20)17-11-22-24(3)12-17;1-22-11-15(10-20-22)14-9-17-18(19-7-8-23(17)12-14)13-3-5-16(6-4-13)21-26(2,24)25/h2-12,14-17H,13H2,1H3,(H,28,31);2-10,12-16H,11H2,1H3,(H,28,31);2-12,14-16H,13H2,1H3,(H,28,31);4-14,23H,1-3H3;3-12,21H,1-2H3
InChIKeyKUYXUKLDHZNQQQ-UHFFFAOYSA-N
XLogP18.86
TPSA381.02 Ų
H-Bond Donors5
H-Bond Acceptors29
Rotatable Bonds24
Heavy Atoms147
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001987.33
LogP ≤ 518.86
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1029

Analyze N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide?
The IUPAC name of N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide (CID 159248417) is N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide.
What is the SMILES notation for N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide?
The canonical SMILES for N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide is CC(C)S(=O)(=O)Nc1ccc(-c2nccn3cc(-c4cnn(C)c4)cc23)cc1.Cn1cc(-c2cc3c(-c4ccc(NC(=O)Cc5ccccc5)cc4)nccn3c2)cn1.Cn1cc(-c2cc3c(-c4ccc(NC(=O)Cc5ccccn5)cc4)nccn3c2)cn1.Cn1cc(-c2cc3c(-c4ccc(NC(=O)Cc5cccnc5)cc4)nccn3c2)cn1.Cn1cc(-c2cc3c(-c4ccc(NS(C)(=O)=O)cc4)nccn3c2)cn1.
What is the InChIKey of N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide?
The InChIKey is KUYXUKLDHZNQQQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H21N5O.2C24H20N6O.C20H21N5O2S.C18H17N5O2S/c1-29-16-21(15-27-29)20-14-23-25(26-11-12-30(23)17-20)19-7-9-22(10-8-19)28-24(31)13-18-5-3-2-4-6-18;1-29-15-20(14-27-29)19-12-22-24(26-9-10-30(22)16-19)18-4-6-21(7-5-18)28-23(31)11-17-3-2-8-25-13-17;1-29-15-19(14-27-29)18-12-22-24(26-10-11-30(22)16-18)17-5-7-20(8-6-17)28-23(31)13-21-4-2-3-9-25-21;1-14(2)28(26,27)23-18-6-4-15(5-7-18)20-19-10-16(13-25(19)9-8-21-20)17-11-22-24(3)12-17;1-22-11-15(10-20-22)14-9-17-18(19-7-8-23(17)12-14)13-3-5-16(6-4-13)21-26(2,24)25/h2-12,14-17H,13H2,1H3,(H,28,31);2-10,12-16H,11H2,1H3,(H,28,31);2-12,14-16H,13H2,1H3,(H,28,31);4-14,23H,1-3H3;3-12,21H,1-2H3.
What are the key properties of N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide?
N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide has a molecular weight of 1987.33 g/mol, XLogP of 18.86, 24 rotatable bonds, 5 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]methanesulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-phenylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]propane-2-sulfonamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-2-ylacetamide;N-[4-[7-(1-methylpyrazol-4-yl)pyrrolo[1,2-a]pyrazin-1-yl]phenyl]-2-pyridin-3-ylacetamide is sourced from PubChem (CID 159248417), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).